346 related articles for article (PubMed ID: 21762579)
1. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
William T; Menon J; Rajahram G; Chan L; Ma G; Donaldson S; Khoo S; Frederick C; Jelip J; Anstey NM; Yeo TW
Emerg Infect Dis; 2011 Jul; 17(7):1248-55. PubMed ID: 21762579
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium knowlesi reinfection in human.
Lau YL; Tan LH; Chin LC; Fong MY; Noraishah MA; Rohela M
Emerg Infect Dis; 2011 Jul; 17(7):1314-5. PubMed ID: 21762601
[No Abstract] [Full Text] [Related]
3. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.
Rajahram GS; Barber BE; William T; Menon J; Anstey NM; Yeo TW
Malar J; 2012 Aug; 11():284. PubMed ID: 22905799
[TBL] [Abstract][Full Text] [Related]
4. Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.
Grigg MJ; William T; Barber BE; Rajahram GS; Menon J; Schimann E; Wilkes CS; Patel K; Chandna A; Price RN; Yeo TW; Anstey NM
Clin Infect Dis; 2018 Jan; 66(2):229-236. PubMed ID: 29020373
[TBL] [Abstract][Full Text] [Related]
5. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
6. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW
Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
[TBL] [Abstract][Full Text] [Related]
7. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Grigg MJ; William T; Dhanaraj P; Menon J; Barber BE; von Seidlein L; Rajahram G; Price RN; Anstey NM; Yeo TW
BMJ Open; 2014 Aug; 4(8):e006005. PubMed ID: 25138814
[TBL] [Abstract][Full Text] [Related]
8. Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria.
Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM
Malar J; 2016 Sep; 15(1):462. PubMed ID: 27613607
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
[TBL] [Abstract][Full Text] [Related]
10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium knowlesi infection imported to Germany, January 2013.
Orth H; Jensen BO; Holtfreter MC; Kocheril SJ; Mallach S; MacKenzie C; Müller-Stöver I; Henrich B; Imwong M; White NJ; Häussinger D; Richter J
Euro Surveill; 2013 Oct; 18(40):. PubMed ID: 24128698
[TBL] [Abstract][Full Text] [Related]
13. Artemether-lumefantrine for uncomplicated malaria: a systematic review.
Omari AA; Gamble C; Garner P
Trop Med Int Health; 2004 Feb; 9(2):192-9. PubMed ID: 15040555
[TBL] [Abstract][Full Text] [Related]
14. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
15. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
[TBL] [Abstract][Full Text] [Related]
16. Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.
Grigg MJ; William T; Barber BE; Rajahram GS; Menon J; Schimann E; Piera K; Wilkes CS; Patel K; Chandna A; Drakeley CJ; Yeo TW; Anstey NM
Clin Infect Dis; 2018 Jul; 67(3):350-359. PubMed ID: 29873683
[TBL] [Abstract][Full Text] [Related]
17. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
Kayentao K; Doumbo OK; Pénali LK; Offianan AT; Bhatt KM; Kimani J; Tshefu AK; Kokolomami JH; Ramharter M; de Salazar PM; Tiono AB; Ouédraogo A; Bustos MD; Quicho F; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
Malar J; 2012 Oct; 11():364. PubMed ID: 23113947
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Sagara I; Diallo A; Kone M; Coulibaly M; Diawara SI; Guindo O; Maiga H; Niambele MB; Sissoko M; Dicko A; Djimde A; Doumbo OK
Am J Trop Med Hyg; 2008 Nov; 79(5):655-61. PubMed ID: 18981499
[TBL] [Abstract][Full Text] [Related]
19. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Owusu-Agyei S; Asante KP; Owusu R; Adjuik M; Amenga-Etego S; Dosoo DK; Gyapong J; Greenwood B; Chandramohan D
PLoS One; 2008 Jun; 3(6):e2530. PubMed ID: 18575626
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
